Alfama
955 Massachusetts Avenue
Suite 581
Cambridge
Massachusetts
02139
United States
Tel: 617-598-1111
About Alfama
Alfama is the leading company in the development of Carbon Monoxide-Releasing Molecules (CORMs) for therapy. The company has produced hundreds of CORMs and obtained exceptional results in various animal models of chronic and acute human diseases. CORMs have the potential to expand CO-based therapy to a wide range of high-value indications, can be administered orally or intravenously, and offer a very attractive therapeutic window and safety profile. After acquiring hemoCORM Ltd of London, UK, Alfama came to control a diverse set of families of patents and patent applications on CORMs which together position the company as the undisputed leader in CORM technology.YEAR FOUNDED:
2005
LEADERSHIP:
CEO: Nuno Arantes-Oliveira